Browsing "School of Medicine" by Author Eadie, L.N.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 6 to 11 of 11 < previous 
PreviewIssue DateTitleAuthor(s)
2022HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohortPage, E.C.; Heatley, S.L.; Eadie, L.N.; McClure, B.J.; de Bock, C.E.; Omari, S.; Yeung, D.T.; Hughes, T.P.; Thomas, P.Q.; White, D.L.
2021In-vitro modeling of TKI resistance in the high-risk B-cell acute lymphoblastic leukemia fusion gene RANBP2-ABL1 - implications for targeted therapyHeatley, S.L.; Asari, K.; Schutz, C.E.; Leclercq, T.M.; McClure, B.J.; Eadie, L.N.; Hughes, T.P.; Yeung, D.T.; White, D.L.
2019KMT2A rearranged acute lymphoblastic leukaemia: unravelling the genomic complexity and heterogeneity of this high-risk diseaseForgione, M.O.; McClure, B.J.; Eadie, L.N.; Yeung, D.T.; White, D.L.
2020MLLT10 rearranged acute leukemia: incidence, prognosis and possible therapeutic strategiesForgione, M.O.; McClure, B.J.; Yeung, D.T.; Eadie, L.N.; White, D.L.
2022Rascall: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL)Rehn, J.; Mayoh, C.; Heatley, S.L.; McClure, B.J.; Eadie, L.N.; Schutz, C.; Yeung, D.T.; Cowley, M.J.; Breen, J.; White, D.L.; Gartenhaus, R.B.
2023The acquisition order of leukemic drug resistance mutations is directed by the selective fitness associated with each resistance mechanismLeow, B.C.S.; Kok, C.H.; Yeung, D.T.; Hughes, T.P.; White, D.L.; Eadie, L.N.